Literature DB >> 9180178

Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.

C Y Chen1, K J Mertz, S M Spinola, S A Morse.   

Abstract

The performance of two EIAs (adsorption EIA and lipooligosaccharide [LOS] EIA) that detect antibodies to Haemophilus ducreyi was evaluated with serum specimens obtained from 163 patients (96 with genital ulcer disease [GUD]). Paired serum specimens (initial and follow-up) were obtained from 52 of the GUD patients. By use of initial serum specimens from 82 GUD patients whose etiologic agents for their ulcers had been identified, the adsorption EIA had a sensitivity and specificity for chancroid of 53% and 71%, while the LOS EIA had a sensitivity and specificity of 48% and 89%, respectively. Sensitivity and specificity of the adsorption EIA increased to 78% and 84%, respectively, when the results of follow-up serum specimens were used to calculate optimal performance. The proportion of patients testing positive for H. ducreyi who had anti-H. ducreyi IgG antibodies, as determined by adsorption EIA, increased with the duration of infection, thus limiting the role of EIAs in the diagnosis of chancroid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180178     DOI: 10.1086/516471

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Development of a serological test for Haemophilus ducreyi for seroprevalence studies.

Authors:  C Elkins; K Yi; B Olsen; C Thomas; K Thomas; S Morse
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 2.  Diagnostic tests for chancroid.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

Review 3.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Putative vaccine candidates and drug targets identified by reverse vaccinology and subtractive genomics approaches to control Haemophilus ducreyi, the causative agent of chancroid.

Authors:  Alissa de Sarom; Arun Kumar Jaiswal; Sandeep Tiwari; Letícia de Castro Oliveira; Debmalya Barh; Vasco Azevedo; Carlo Jose Oliveira; Siomar de Castro Soares
Journal:  J R Soc Interface       Date:  2018-05       Impact factor: 4.118

5.  Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi.

Authors:  P A Totten; J M Kuypers; C Y Chen; M J Alfa; L M Parsons; S M Dutro; S A Morse; N B Kiviat
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects.

Authors:  V Gelfanova; T L Humphreys; S M Spinola
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid.

Authors:  Isabelle Leduc; William G Fusco; Neelima Choudhary; Patty A Routh; Deborah M Cholon; Marcia M Hobbs; Glen W Almond; Paul E Orndorff; Christopher Elkins
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

8.  Examination of early interactions between Haemophilus ducreyi and host cells by using cocultured HaCaT keratinocytes and foreskin fibroblasts.

Authors:  F R Zaretzky; T H Kawula
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

9.  A humoral immune response confers protection against Haemophilus ducreyi infection.

Authors:  Leah E Cole; Kristen L Toffer; Robert A Fulcher; Lani R San Mateo; Paul E Orndorff; Thomas H Kawula
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.

Authors:  Galyna Afonina; Isabelle Leduc; Igor Nepluev; Chrystina Jeter; Patty Routh; Glen Almond; Paul E Orndorff; Marcia Hobbs; Christopher Elkins
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.